CRAWFORDVILLE, Fla. — Hurricane Helene weakened to a tropical storm over Georgia with maximum sustained winds of 70 mph (110 ...

The federal program has been reopened on the heels of a summer COVID-19 virus wave and heading into the fall and winter ...

New patent expected to provide market exclusivity into 2036 Zembrace® SymTouch® (sumatriptan succinate injection) 10mg is indicated for the acute treatment of migraine in adults CHATHAM, N.J., Sept.

Drinking too much coffee has a reputation of being harmful, but a new study says having three cups a day can lower the risk of developing more than one cardiometabolic disease.

Biomea Fusion has escaped from the full clinical hold imposed by the FDA. | Biomea Fusion has escaped from the full clinical hold imposed by the FDA. After reviewing the data, the regulator has ...

Mumbai: Alembic Pharmaceuticals Limited today announced that it has received final approval from the US Food & Drug ...

The gene therapy comes seven years after another research group at the university helped come up with the first FDA approved gene therapy for an inherited disease.

Scientists comment on the FDA approving Cobenfy (KarXT) for schizophrenia. Dr Sameer Jauhar, Senior Clinical Lecturer in Affective Disorders and Psychosis, Consultant Psychiatrist, King’s College, ...

A popular podcast mentioned it earlier this year, sources say, but the FDA suggests users should be aware of unlisted ingredients.

The U.S. Food and Drug Administration (FDA) on Thursday approved Cobenfy (xanomeline and trospium chloride), developed by ...

Bristol Myers Squibb stock jumped after the pharma company won approval for its new schizophrenia drug late Thursday. “This drug takes the first new approach to schizophrenia treatment in decades,” ...

The study will evaluate the safety, tolerability and pharmacokinetic characteristics of the company's exenatide implant.